Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of the American Society of Nephrology

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9048346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.

  1995cited by this paper
• Cellular mechanisms of tubule hypertrophy and hyperplasia in renal injury.

  1995cited by this paper
• Gene expression after uninephrectomy in the rat: simultaneous expression of positive and negative growth control elements.

  1995cited by this paper
• RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation.

  1995cited by this paper
• The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element.

  1994cited by this paper
• Regulation of calcitriol receptor and its mRNA in normal and renal failure rats.

  1994cited by this paper
• The Remnant Kidney Model

  1993cited by this paper
• Effects of l α,25-Dihydroxyvitamin D3 on Compensatory Renal Growth in the Growing Rat

  1993cited by this paper
• Vitamin D-regulated gene expression.

  1993cited by this paper
• Mechanism of decreased intestinal calcitriol receptor concentration in renal failure.

  1993cited by this paper
• Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

  1993cited by this paper
• Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.

  1993cited by this paper
• A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements.

  1992cited by this paper
• No decrease of 1,25(OH)2D3 receptors and duodenal calbindin‐D9k in uraemic rats

  1991cited by this paper
• Vitamin D3 receptors: structure and function in transcription.

  1991cited by this paper
• Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.

  1991cited by this paper
• Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3.

  1990cited by this paper
• 25-Hydroxyvitamin D metabolism and its effect on calcitriol metabolism in experimental renal failure.

  1990cited by this paper
• Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression.

  1990cited by this paper
• 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs.

  1989cited by this paper
• 1,25-Dihydroxyvitamin D3 and the Regulation of Human Cancer Cell Replication 1

  1989cited by this paper
• Determinants of target gene specificity for steroid/thyroid hormone receptors.

  1989cited by this paper
• 1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo.

  1989cited by this paper
• Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia.

  1987influential reference
• Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.

  1987cited by this paper
• Inhibitory effect of 1α,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line

  1986cited by this paper
• Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line.

  1986cited by this paper
• Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice

  1985cited by this paper
• On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency.

  1985cited by this paper
• Calciuric response to 1,25-(OH)2D3 in early renal failure.

  1985cited by this paper
• Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

  1984cited by this paper
• Determinants of serum 1,25(OH)2D levels in renal disease.

  1983cited by this paper
• Regulation of 1,25(OH)2 vitamin D3 receptor content in cultured LLC-PK1 kidney cells limits hormonal responsiveness.

  1983cited by this paper
• A new semiautomatic method for quantitative static and dynamic bone histology

  1982cited by this paper
• Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

  1981cited by this paper
• An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes.

  1979cited by this paper
• Bone histology in incipient and advanced renal failure.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Determination of inulin in plasma and urine by use of anthrone.

  1954cited by this paper
• Determination of inulin in plasma and urine by use of anthrone.

  1954cited by this paper

• The role of nutritional vitamin D in chronic kidney disease–mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation—a European consensus statement

  2025cites this paper
• 25(OH)D-but not 1,25(OH)2D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients

  2023cites this paper
• Chapter 2 Vitamin D and Renal Disease

  2019cites this paper
• Vitamin D Deficiency in Renal Disease

  2019cites this paper
• Vitamin D and Renal Disease

  2017cites this paper
• Vitamin D and Renal Disease Vitamin D and Renal Disease

  2017cites this paper
• Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies

  2017cites this paper
• Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?

  2014cites this paper
• Vitamin D and Renal Disease

  2011cites this paper
• Severe osteomalacia caused by short bowel syndrome in a patient on long-term hemodialysis after parathyroidectomy

  2011cites this paper
• Biological and Molecular Effects of Vitamin D on the Kidney

  2010cites this paper
• Suppression of parathyroid hormone production in vitro and in vivo by RNA interference.

  2009cites this paper
• Mecanismos de calcificación vascular asociados a la uremia y al tratamiento con Calcitriol.

  2009cites this paper
• Vitamin D: Molecular Biology and Gene Regulation

  2009cites this paper
• Thyroid hormone action in chronic kidney disease

  2008cites this paper
• Pathophysiology of renal osteodystrophy

  2007cites this paper
• Metabolic bone disease in chronic kidney disease.

  2007influential citation
• Disease of the Month Metabolic Bone Disease in Chronic Kidney Disease

  2007influential citation
• CHAPTER 103 – Renal Failure and Secondary Hyperparathyroidism

  2005cites this paper
• Thyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxins

  2005influential citation
• Calcium and phosphorus metabolism in patients who have chronic kidney disease.

  2005cites this paper
• Vitamin D receptor and analogs.

  2004cites this paper
• Vitamin D receptor: mechanisms for vitamin D resistance in renal failure.

  2003cites this paper
• Stimulation of osteoclastic bone resorption in a model of glycerol-induced acute renal failure: evidence for a parathyroid hormone-independent mechanism.

  2002cites this paper
• Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease.

  2002cites this paper
• Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects.

  2001cites this paper
• Blunted response to vitamin D in uremia.

  2001cites this paper
• The anti-proliferative effect of calcitriol on HL-60 cells is neutralized by uraemic biological fluids.

  2001cites this paper
• Retinoic acid reduces glomerular injury in a rat model of glomerular damage.

  2000cites this paper
• Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.

  2000cites this paper
• Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow.

  2000cites this paper
• Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro.

  2000cites this paper
• Pathogenesis and Treatment of Secondary Hyperparathyroidism in Chronic Renal Disease

  1999cites this paper
• Cannella-editoriale 1

  1999cites this paper
• Molecular mechanisms of vitamin D hyporesponsiveness in renal failure.

  1999cites this paper
• Molecular pathogenesis of secondary hyperparathyroidism in renal failure: basic and clinical aspects.

  1999cites this paper
• Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease.

  1998cites this paper
• Molecular pathogenesis of secondary hyperparathyroidism in renal failure : basic and clinical aspects

  1998cites this paper
• Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure.

  1998cites this paper
• Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency.

  1998cites this paper
• CHAPTER 76 – Vitamin D and Renal Failure

  1997cites this paper
• Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management.

  1997cites this paper